CVS Corp
(CVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,256,000 | 14,869,000 | 10,081,000 | 5,683,000 | 5,193,000 |
| Marketable Securities | 2,831,000 | 2,596,000 | 2,632,000 | 2,373,000 | 2,334,000 |
| Receivables | 23,816,000 | 22,520,000 | 23,037,000 | 19,617,000 | 19,789,000 |
| Inventories | 17,478,000 | 16,519,000 | 16,976,000 | 17,516,000 | 16,028,000 |
| Other current assets | 5,830,000 | 6,002,000 | 6,232,000 | 5,113,000 | 4,841,000 |
| TOTAL | $59,211,000 | $62,506,000 | $58,958,000 | $50,302,000 | $48,185,000 |
| Non-Current Assets | |||||
| PPE Net | 12,349,000 | 12,221,000 | 12,146,000 | 12,044,000 | 11,651,000 |
| Investments And Advances | 20,216,000 | 18,594,000 | 16,840,000 | 17,314,000 | 17,342,000 |
| Intangibles | 111,276,000 | 112,282,000 | 112,720,000 | 112,870,000 | 113,203,000 |
| Other Non-Current Assets | 29,846,000 | 29,892,000 | 29,975,000 | 29,919,000 | 29,732,000 |
| TOTAL | $173,687,000 | $172,989,000 | $171,681,000 | $172,147,000 | $171,928,000 |
| Total Assets | $232,898,000 | $235,495,000 | $230,639,000 | $222,449,000 | $220,113,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,443,000 | 8,192,000 | 6,083,000 | 3,781,000 | 4,848,000 |
| Accounts payable and accrued liabilities | 34,992,000 | 32,822,000 | 33,257,000 | 30,972,000 | 29,555,000 |
| Accrued Expenses | 14,329,000 | 15,634,000 | 13,574,000 | 12,133,000 | 11,615,000 |
| Other current liabilities | 5,491,000 | 5,280,000 | 4,884,000 | 4,821,000 | 4,728,000 |
| TOTAL | $62,044,000 | $63,694,000 | $59,560,000 | $53,303,000 | $52,544,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 61,552,000 | 63,481,000 | 65,735,000 | 64,699,000 | 64,206,000 |
| Other Non-Current Liabilities | 32,942,000 | 32,818,000 | 32,744,000 | 32,986,000 | 33,152,000 |
| TOTAL | $101,742,000 | $103,446,000 | $105,605,000 | $104,976,000 | $104,636,000 |
| Total Liabilities | $163,786,000 | $167,140,000 | $165,165,000 | $158,279,000 | $157,180,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,308,914 | 1,308,703 | 1,307,091 | 1,304,160 | 1,300,964 |
| Common Shares | 46,388,000 | 46,276,000 | 46,180,000 | 45,972,000 | 45,854,000 |
| Retained earnings | 49,328,000 | 48,768,000 | 46,455,000 | 45,108,000 | 44,017,000 |
| Other shareholders' equity | 1,560,000 | 1,546,000 | 1,021,000 | 1,325,000 | 1,269,000 |
| TOTAL | $69,112,000 | $68,355,000 | $65,474,000 | $64,170,000 | $62,933,000 |
| Total Liabilities And Equity | $232,898,000 | $235,495,000 | $230,639,000 | $222,449,000 | $220,113,000 |